title: [Extrasecretory liver function disorder in patients with chronic pancreatitis].
abstract: Bile production and bile secretion studies in 112 patients with primary chronic pancreatitis have demonstrated. Duodenal intubational chromatic examination can be used in addition to standard laboratory and device methods for early diagnosis of "biliary insuffiency" and cholelithiasis. The analysis of efficacy of Ursofalk was made in 30 patients with chronic pancreatitis. Patients received Ursofalk in a dose 10 mg/kg/day for one month. It was established that Ursofalk stabilizes bile secretion and removes biliary insuffiency.
authors.forename: V A
authors.initials: VA
authors.lastname: Maksimov
authors.forename: A L
authors.initials: AL
authors.lastname: Chernyshev
authors.forename: E E
authors.initials: EE
authors.lastname: Shelemov
mesh_terms: D015746:Abdominal Pain / Q000150:complications; D000328:Adult; D001646:Bile / Q000737:chemistry / Q000378:metabolism*; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005704:Gallbladder / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D050500:Pancreatitis, Chronic / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D009803:Sphincter of Oddi / Q000378:metabolism; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid